Carroll Kecia N, Wu Pingsheng, Gebretsadik Tebeb, Griffin Marie R, Dupont William D, Mitchel Edward F, Hartert Tina V
Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tenn; Division of General Pediatrics, Vanderbilt University School of Medicine, Nashville, Tenn 37232-8300, USA.
J Allergy Clin Immunol. 2009 May;123(5):1055-61, 1061.e1. doi: 10.1016/j.jaci.2009.02.021. Epub 2009 Apr 10.
Infants hospitalized for bronchiolitis have a high rate of early childhood asthma. It is not known whether bronchiolitis severity correlates with the risk of early childhood asthma or with asthma-specific morbidity.
We sought to determine whether a dose-response relationship exists between severity of infant bronchiolitis and both the odds of early childhood asthma and asthma-specific morbidity.
We conducted a population-based retrospective birth cohort study of term healthy infants born from 1995-2000 and enrolled in a statewide Medicaid program. We defined bronchiolitis severity by categorizing infants into mutually exclusive groups based on the most advanced level of health care for bronchiolitis. Health care visits, asthma-specific medications, and demographics were identified entirely from Medicaid and linked vital records files. Asthma was ascertained at between 4 and 5.5 years of age, and 1-year asthma morbidity (hospitalization, emergency department visit, or oral corticosteroid course) was determined between 4.5 and 5.5 years among children with prevalent asthma.
Among 90,341 children, 18% had an infant bronchiolitis visit, and these infants contributed to 31% of early childhood asthma diagnoses. Relative to children with no infant bronchiolitis visit, the adjusted odds ratios for asthma were 1.86 (95% CI, 1.74-1.99), 2.41 (95% CI, 2.21-2.62), and 2.82 (95% CI, 2.61-3.03) in the outpatient, emergency department, and hospitalization groups, respectively. Children hospitalized with bronchiolitis during infancy had increased early childhood asthma morbidity compared with that seen in children with no bronchiolitis visit.
To our knowledge, this is the first study to demonstrate the dose-response relationship between the severity of infant bronchiolitis and the increased odds of both early childhood asthma and asthma-specific morbidity.
因毛细支气管炎住院的婴儿患儿童期哮喘的几率很高。目前尚不清楚毛细支气管炎的严重程度是否与儿童期哮喘风险或哮喘特异性发病率相关。
我们试图确定婴儿毛细支气管炎的严重程度与儿童期哮喘几率及哮喘特异性发病率之间是否存在剂量反应关系。
我们对1995年至2000年出生的足月儿且参加了全州医疗补助计划的健康婴儿进行了一项基于人群的回顾性出生队列研究。我们根据毛细支气管炎最先进的医疗护理水平将婴儿分为相互排斥的组来定义毛细支气管炎的严重程度。医疗就诊、哮喘特异性药物和人口统计学信息完全从医疗补助计划及相关生命记录文件中获取。在4至5.5岁时确定是否患有哮喘,对于患有哮喘的儿童,在4.5至5.5岁时确定其1年的哮喘发病率(住院、急诊就诊或口服糖皮质激素疗程)。
在90341名儿童中,18%的儿童有婴儿期毛细支气管炎就诊记录,这些婴儿占儿童期哮喘诊断病例的31%。与没有婴儿期毛细支气管炎就诊记录的儿童相比,门诊、急诊和住院组哮喘的校正比值比分别为1.86(95%CI,1.74 - 1.99)、2.41(95%CI,2.21 - 2.62)和2.82(95%CI,2.61 - 3.03)。婴儿期因毛细支气管炎住院的儿童与没有毛细支气管炎就诊记录的儿童相比,儿童期哮喘发病率更高。
据我们所知,这是第一项证明婴儿毛细支气管炎严重程度与儿童期哮喘几率增加及哮喘特异性发病率增加之间存在剂量反应关系的研究。